Sam Brusco, Associate Editor07.12.23
AlloSource, an allograft provider creating cellular and tissue products to help heal patients, has gained U.S. Food and Drug Administration (FDA) 510(k) clearance for its AceConnex pre-sutured fascia for hip labral reconstruction and augmentation.
AceConnex reinforces the company’s commitment to providing products for the sports medicine market, including hip arthroscopy.
"AceConnex Pre-Sutured Fascia was designed to help hip arthroscopists efficiently treat their patients by eliminating time and tedious effort associated with suturing in the OR," Carolyn Rorick, AlloSource senior director product development, innovation, and clinical affairs told the press. "We spent an extensive amount of time perfecting our design and suturing technique to ensure consistency and that design is now patented."
The pre-sutured fascia is meant as a component in soft tissue surgical procedures where constructs, including those with allograft tissue, are used for labrum reconstruction, replacement, or augmentation. The sterile device is available in various pre-sutured sizes, with trimmable regions that allow allograft adjustments to match anatomy.
AceConnex pre-sutured fascia is manufactured to ensure consistency and minimize variability compared to allografts that are manually sutured pre-operatively.
"AceConnex Pre-Sutured Fascia is integral to our mission of providing innovative allografts to advance patient healing," said Dean Elliott, AlloSource president and CEO. "We are proud to be first to market with an FDA cleared pre-sutured fascia device to meet the varying needs of hip arthroscopists and patients."
AceConnex reinforces the company’s commitment to providing products for the sports medicine market, including hip arthroscopy.
"AceConnex Pre-Sutured Fascia was designed to help hip arthroscopists efficiently treat their patients by eliminating time and tedious effort associated with suturing in the OR," Carolyn Rorick, AlloSource senior director product development, innovation, and clinical affairs told the press. "We spent an extensive amount of time perfecting our design and suturing technique to ensure consistency and that design is now patented."
The pre-sutured fascia is meant as a component in soft tissue surgical procedures where constructs, including those with allograft tissue, are used for labrum reconstruction, replacement, or augmentation. The sterile device is available in various pre-sutured sizes, with trimmable regions that allow allograft adjustments to match anatomy.
AceConnex pre-sutured fascia is manufactured to ensure consistency and minimize variability compared to allografts that are manually sutured pre-operatively.
"AceConnex Pre-Sutured Fascia is integral to our mission of providing innovative allografts to advance patient healing," said Dean Elliott, AlloSource president and CEO. "We are proud to be first to market with an FDA cleared pre-sutured fascia device to meet the varying needs of hip arthroscopists and patients."